摘要
Rifampicin is a macrocyclic antibiotic used extensively for the treatment of Mycobacterium tuberculosis and other mycobacterial infections. Recently, it was discovered that rifampicin exhibits neuroprotective effects. It has been shown to protect PC12 cells against MPP+-induced apoptosis and inhibit the expression of alpha-synuclein multimers. In in vitro studies, rifampicin pretreatment protects PC12 cells against rotenone-induced cell death. Qualitative and quantitative analyses uncover that rifampicin significantly suppresses rotenone-induced apoptosis by ameliorating mitochondrial oxidative stress. It reduces microglial inflammation and improves neuron survival. Our results indicate that rifampicin is cytoprotective under a variety of experimental conditions, and suggest that it may be useful in PD therapeutics. It is the aim of this paper to review the experimental neuroprotection data reported using rifampicin with a focus on the molecular and cellular mechanisms of cytoprotective effect in in vitro models of PD.
学科与关键词
- Rifampicin Protects PC12 Cells from Rotenone-Induced Cytotoxicity by Activating GRP78 via PERK-eIF2 alpha-ATF4 PathwayJing Xiuna; Shi Qiaoyun; Bi Wei; Zeng Zhifen; Liang Yanran; Wu Xia; Xiao Songhua; Liu Jun; Yang Lianhong; Tao Enxiang*PLoS ONE, 2014, 9(3): e92110.被引 3
- Rifampicin inhibits microglial inflammation and improves neuron survival against inflammationBi Wei; Zhu Lihong; Wang Chuanming; Liang Yanran; Liu Jun; Shi Qiaoyun; Tao Enxiang*Brain Research, 2011, 1395: 12-20.被引 28
- RIFAMPICIN: An antibiotic with brain protective functionYulug Burak; Hanoglu Lutfu; Kilic Ertugrul; Schabitz Wolf RuedigerBrain Research Bulletin, 2014, 107: 37-42.
